MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

MetaVia Inc. jumped in U.S. pre-market trade Tuesday after saying three late-breaking abstracts for its cardiometabolic drug programs got into the American Diabetes Association’s 2026 Scientific Sessions. The biotech’s shares were at $1.86, up 67.6% from Monday’s close at $1.11, as of 07:02 a.m. EDT, according to MarketScreener. The stock trades on Nasdaq.

19 May 2026

LSE:DPL · Stock Market

Diploma PLC stock price drops 3.5% as Trump tariff threat jars FTSE 100 mood

Diploma PLC’s shares slid 3.5% to 5,487.8 pence by 1252 GMT on Monday, pulling back from last week’s 52-week high of 5,760 pence. The FTSE 100 firm, known for supplying seals, controls, and life sciences products, earns about 46% of its revenue in the US.

19 January 2026

FTSE 100·LSE:DPL·Stock Market

Diploma PLC stock price drops 3.5% as Trump tariff threat jars FTSE 100 mood

TechStock² Updates

Marvell Shares Drop 10.3%, Wiping Out $22 Billion Amid Google Revenue Delay to 2029

Ambev Shares Slide 0.7%, 30 Million Shares Test 31.6% Margin Rebound

Coeur Mining Stock Falls 4.9%, Erasing $1.1 Billion as Metals Slide

B2Gold Reports Masbate Fatality After Stock Falls 2.9%; Production Continues

IREN Shares Drop 12.5% With $4 Billion AI Expansion Pushing Up Against $6.4 Billion Financing Hurdle

NVIDIA Sheds 4.6% and Loses $252 Billion in Value as Margin Concerns Emerge Over Memory Prices

SpaceX Shares Edge Up 0.5% with $1.86 Trillion Value as Quarterly Capex Hits $18.4 Billion

Intel Shares Drop 2.9%, Remain 5.8% Under $95 Offering as Company Delivers 25% Revenue Gain

PG&E Shares Drop 7.5%, Wiping Out $3 Billion After Delay to California Wildfire Shield

DraftKings Faces $67.6 Million Loss on $13.1 Billion U.S. Open Betting Volume

Investment Disclaimer